Sytheon Granted 2 New US Patents on Isosorbide Diesters for Treating Atopic Dermatitis, Seeking Exclusive Partner to Bring to Market

Sytheon is thrilled to announce that its new turnkey product for treating Atopic Dermatitis (eczema) has further patent protection – and is actively seeking an exclusive partner to bring it to the OTC dermatological market.

There is currently an unmet need for a sustainable, safe, and cost-effective product for those with mild to moderate Atopic Dermatitis (AD). Sytheon has a turnkey product, ActSES®, with solid science, patent protection, and clinical validation by UC-Davis, CA dermatologists – and a new clinical study on children underway.

Market Opportunity for Atopic Dermatitis (AD)

Topical therapies are a mainstay treatment for AD, particularly for children or those with mild-to-moderate disease who may not qualify for systemic medications. The complexity of chronic AD is increased by the interplay of skin barrier dysfunction and immune dysregulation, resulting in the perpetuation of AD signs and symptoms.

ActSES®, a unique synergistic combination product of Isosorbide di-(linoleate/oleate) (Hydra Synol® IDL) + Isosorbide di-caprylate (Hydra Synol® DOI), has been developed by Sytheon to serve this unmet need. The effects of topically applied ActSES® are not limited to barrier repair but synergistically inhibit inflammatory cascades that amplify pruritus and cutaneous eruption.

For ActSES®, Sytheon has obtained two new US patents 11,753,414 (method) & 11,753,415 (composition), entitled “Composition and Methods for Treating Atopic Dermatitis.” Sytheon has two earlier US Patents (10,597,402 & 11,312,725), which disclose “compositions and methods for restoring epidermal integrity and function and treating dermatol­ogical diseases.”

Sytheon is actively looking for an exclusive partnership with the right organization to bring this turnkey product to the OTC dermatological market. To inquire, please send us a message here.

This news piece is also featured on SpecialChem and HAPPI.

About Sytheon

Sytheon is an innovative research-focused company committed to developing high-performance active ingredients for the personal care industry. Inspired by nature, all of Sytheon’s ingredients have been scientifically and clinically validated to improve the health and beauty of the skin.

Visit our website: www.sytheonltd.com

Dr. Ratan K. Chaudhuri is an innovator passionate about helping others, which led to a career in personal care and starting Sytheon in 2006.
Sytheon is actively seeking an exclusive partner to bring its new turnkey product for treating Atopic Dermatitis (eczema) to market.
Hexylresorcinol's benefits as an active ingredient for skin care applications have only begun to be realized.
In a recent study, Pierre Fabre researchers evaluated the effects of Synastol® TC (Terminalia Chebula Fruit Extract) on Senomorphic Targets.
To meet consumer needs, beauty brands must use skincare active ingredients that are scientifically proven to perform.
Sytheon, a global supplier of unique and multifunctional active ingredients, is participating in this year’s Suppliers’ Day in Singapore.
Helping Others with Better Personal Care Ingredients: Sytheon’s Founder Story

Helping Others with Better Personal Care Ingredients: Sytheon’s Founder Story

At an early age, Ratan K. Chaudhuri, PhD, discovered he could leverage scientific research to improve people’s lives. This philosophy...

by Dr. Ratan K. ChaudhuriNovember 30, 2023
Read More
Sytheon Granted 2 New US Patents on Isosorbide Diesters for Treating Atopic Dermatitis, Seeking Exclusive Partner to Bring to Market

Sytheon Granted 2 New US Patents on Isosorbide Diesters for Treating Atopic Dermatitis, Seeking Exclusive Partner to Bring to Market

Sytheon is thrilled to announce that its new turnkey product for treating Atopic Dermatitis (eczema) has further patent protection –...

by Dr. Ratan K. ChaudhuriNovember 3, 2023
Read More
Hexylresorcinol in Skin Care: Short Guide to Synovea® HR

Hexylresorcinol in Skin Care: Short Guide to Synovea® HR

Hexylresorcinol has a 95-year history of use in food and pharmaceuticals, but its benefits as an active ingredient for skin...

by Dr. Ratan K. ChaudhuriOctober 24, 2023
Read More
Synastol® TC (Terminalia Chebula Fruit Extract): A Multifunctional Ingredient for Well-Aging Products

Synastol® TC (Terminalia Chebula Fruit Extract): A Multifunctional Ingredient for Well-Aging Products

In a recent study published in the International Journal of Cosmetic Science, Pierre Fabre researchers evaluated the effects of Synastol®...

by Dr. Ratan K. ChaudhuriSeptember 28, 2023
Read More
Science Meets Beauty: 10 Active Ingredients that Will Enhance Your Skincare Formulation

Science Meets Beauty: 10 Active Ingredients that Will Enhance Your Skincare Formulation

Today’s personal care consumers are vigilant about the ingredients used in their favorite skincare products. They want to know exactly...

by Dr. Ratan K. ChaudhuriSeptember 8, 2023
Read More
Sytheon Takes on Suppliers’ Day in Singapore: Speaking Session & Partner Booth

Sytheon Takes on Suppliers’ Day in Singapore: Speaking Session & Partner Booth

Sytheon, a global supplier of unique and multifunctional active ingredients, is thrilled to announce its participation at this year’s Suppliers’...

by Dr. Ratan K. ChaudhuriSeptember 7, 2023
Read More
document.addEventListener("DOMContentLoaded", function() { var postTitles = document.querySelectorAll('.blfe-post-grid-title'); // Replace '.post-title-class' with the actual class or element selector for your post titles postTitles.forEach(function(title) { title.removeAttribute('rel'); }); });